Evidence map›Paper›PMID 39654392›Full record

ArticleLeukemia & lymphoma2025

Megakaryocyte centrosomal and Golgi structural perturbations in patients with primary myelofibrosis and with

Ifeyinwa E Obiorah, Debamita Kundu, Folashade Adekunle, Patcharin Pramoonjago, Katherine R Calvo, Paul Liu, Adam Goldfarb

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ifeyinwa E ObiorahDepartment of Pathology, University of Virginia Health, Charlottesville, VA, USA.
Debamita KunduDepartment of Biostatistics, University of Virginia, Charlottesville, VA, USA.
Folashade AdekunleDepartment of Pathology, University of Virginia Health, Charlottesville, VA, USA.
Patcharin PramoonjagoDepartment of Pathology, University of Virginia Health, Charlottesville, VA, USA.
Katherine R CalvoDepartment of Laboratory Medicine, National Institutes of Health Clinical Center, NIH, Bethesda, MD, USA.
Paul LiuGenetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Adam GoldfarbDepartment of Pathology, University of Virginia Health, Charlottesville, VA, USA.

Funding

Targeting Dyrk1a to Promote Donor-independent Platelet ProductionR01HL149667 · NHLBI · UNIVERSITY OF VIRGINIA · PI GOLDFARB, ADAM N. · 2020 to 2023
$2.8M
NHLBI NIH HHS R01 HL149667
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39654392
PMCPMC11952982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.